Cigna Group (NYSE:CI – Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 30.450- for the period, compared to the consensus estimate of 30.510. The company issued revenue guidance of $280.0 billion-$280.0 billion, compared to the consensus revenue estimate of $287.2 billion.
Wall Street Analyst Weigh In
Several research firms recently weighed in on CI. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Guggenheim upped their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Mizuho increased their target price on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Wells Fargo & Company lifted their price target on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, September 26th. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $337.10.
Read Our Latest Report on Cigna Group
Cigna Group Stock Performance
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. The firm had revenue of $71.56 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the business earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts expect that Cigna Group will post 30.51 EPS for the current year.
Cigna Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th were issued a $1.56 dividend. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio is presently 25.82%.
Insider Activity at Cigna Group
In other Cigna Group news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 19,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 22,730 shares of company stock valued at $6,293,359. Company insiders own 0.60% of the company’s stock.
Key Stories Impacting Cigna Group
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Cigna introduced its “Lead to One” strategy, targeting personalized, more affordable care through clinical expertise, data, technology and artificial intelligence. Management expects adjusted EPS to grow at a 10%–14% compound annual rate through 2030, a potentially attractive long-term growth profile for a company trading at a relatively modest valuation. Cigna Investor Day announcement
- Positive Sentiment: The company plans to invest $3 billion over several years in workflow modernization, productivity and technology, while increasing its focus on specialty pharmacy and complex-care services. These investments could improve operating efficiency and strengthen Cigna’s position in higher-growth healthcare segments. Cigna $3 billion investment report
- Positive Sentiment: Cigna reaffirmed its 2026 adjusted EPS guidance and announced an exclusive international healthcare agreement with UnitedHealthcare Global, which may expand its global capabilities and distribution. Cigna international agreement
- Neutral Sentiment: Analysts broadly maintain a “Moderate Buy” consensus, suggesting expectations remain favorable but not overwhelmingly bullish. Cigna analyst consensus
- Negative Sentiment: Cigna’s 2026 revenue guidance of $280 billion is below the roughly $287.2 billion analyst consensus, while EPS guidance of $30.45 is slightly below the $30.51 estimate. The gap could temper enthusiasm and places greater emphasis on successful execution of the investment plan. Cigna financial targets
Cigna Group Company Profile
The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.
Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.
Recommended Stories
- Five stocks we like better than Cigna Group
- Boeing’s Fighter Victory Opens the Door to Decades of Defense Revenue
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
